InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Voyager Therapeutics, Inc.

VYGR Clue Score26
United States Fiscal year ends December CIK 0001640266 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Alfred Sandrock
2 Apr 2026
President and CEO
Sold on a plan
11,511
$3.87
$44.55K
Todd Alfred Carter
24 Feb 2026
Chief Scientific Officer
Sold on a plan
4,174
$3.76
$15.69K
Nathan D. Jorgensen
24 Feb 2026
Chief Financial Officer
Sold on a plan
4,668
$3.77
$17.60K
Alfred Sandrock
24 Feb 2026
President and CEO
Sold on a plan
14,197
$3.79
$53.81K
Robin Swartz
24 Feb 2026
COO & Cbo
Sold on a plan
6,458
$3.77
$24.35K
Alfred Sandrock
18 Feb 2026
President and CEO
Sold on a plan
11,732
$3.41
$40.01K
Todd Alfred Carter
18 Feb 2026
Chief Scientific Officer
Sold on a plan
3,301
$3.44
$11.36K
Robin Swartz
18 Feb 2026
COO & Cbo
Sold on a plan
3,882
$3.44
$13.35K
Nathan D. Jorgensen
3 Oct 2025
Chief Financial Officer
Sold on a plan
7,666
$4.78
$36.64K
Todd Alfred Carter
6 Jul 2023
Chief Scientific Officer
Sold on a plan
5,500
$10.80
$59.40K
Show all 123 transactions →

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 10
Sales straight out of an exercise 7
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 13,599,620
Sales filed before the plan box existed 67
History held since 18 Nov 2015